ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,211, issued on Sept. 9, was assigned to Allergan Inc. (Irvine, Calif.).
"Non-protein Clostridial toxin compositions" was invented by Maurice Abiad (Anaheim, Calif.), Bhas Dani (San Diego) and Evgenyi Shalaev (Dana Point, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions that stabilize a Clostridial toxin active ingredient are described. The compositions can be liquid or solid compositions, and comprise a surfactant and an antioxidant. In some embodiments, the compositions comprise a surfactant selected from a poloxamer and a polysorbate; an antioxidant selected from methionine, N-acetyl cysteine, ethylenediaminetetra...